Search

Your search keyword '"Kuziemski K"' showing total 4 results
Start Over Author "Kuziemski K" Publisher aluna publishing
4 results on '"Kuziemski K"'

1. [Hyperlucent lung syndrom caused by pulmonary artery hypoplasia in patient with diagnosed asthma--case report].

Author

Górska L, Kuziemski K, Wajda B, Damps-Konstańska I, Tokarska B, and Jassem E

Subjects
Aged, Asthma drug therapy, Female, Humans, Lung, Hyperlucent diagnostic imaging, Pulmonary Artery diagnostic imaging, Tomography, X-Ray Computed, Asthma etiology, Lung, Hyperlucent diagnosis, Lung, Hyperlucent etiology, Pulmonary Artery abnormalities
Abstract

We present case of 67-years-old, non-smoking woman with unilateral hyperlucent lung syndrome. She has diagnosed asthma and since 1997 she has been treated with inhaled corticosteroids and long-acting beta-agonists without improvement. She complained of a cough, shortness of breath, pulmonary function test reveal irrvesibility airflow obstruction. The routine X-ray chest showed unilateral hyperlucent left lung. Ct-angiography has shown unilateral hypoplasia of pulmonary artery. It indicates that in all cases of uncontrolled asthma should be considered another or coexisting diagnosis.

Published
2008

2. [Malignant mesothelioma of the pleura--diagnostic difficulties].

Author

Drozdowska A, Damps-Konstańska I, Kobierska-Gulida G, Madrzak J, Kuziemski K, Pieńkowska J, Ucińska R, and Słomiński JM

Subjects
Biopsy, Diagnosis, Differential, Humans, Male, Middle Aged, Thoracoscopy, Mesothelioma diagnosis, Mesothelioma surgery, Pleura pathology, Pleural Neoplasms diagnosis, Pleural Neoplasms surgery
Abstract

Malignant mesothelioma of the pleura is a rare neoplasm with a poor prognosis. Noncharacteristic clinical signs, radiological features and similarity to other neoplasma (adenocarcinoma) in a microscopical evaluation lead to often diagnostic problems. Thoracoscopy followed by biopsy is routinely performed and is considered a main diagnostic procedure. Microscopic samples are usually examined by immunohistochemical analysis. In this report, presented is a case of malignant pleural mesothelioma, in which final diagnosis was delayed because of difficulties in diagnosis based on thoracoscopic biopsy.

Published
2004

3. [Addison's diseases caused by adrenal tuberculosis--case report].

Author

Kuziemski K, Porzezińska M, Kuziemska B, Wolska-Goszka L, and Słomiński JM

Subjects
Addison Disease diagnostic imaging, Adrenal Cortex Hormones therapeutic use, Antitubercular Agents therapeutic use, Female, Humans, Middle Aged, Radiography, Tuberculosis, Endocrine drug therapy, Addison Disease microbiology, Adrenal Glands microbiology, Tuberculosis, Endocrine complications
Abstract

A case of adrenal tuberculosis with acute Addison's disease is described. The disease manifested acute as suprarenal crisis. Metastatic and autoimmunological (antisuprarenal antibodies were not found) etiology was excluded. Computed tomography demonstrated calcifications in both, enlarged adrenals. After antituberculosis treatment and corticosteroid therapy we observed significant improvement in our patient's condition.

Published
2004

4. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].

Author

Kuziemski K, Mincewicz G, Sopel R, and Słomiński JM

Subjects
Health Care Costs, Humans, Leukotriene Antagonists pharmacology, Lipoxygenase Inhibitors pharmacology, Asthma drug therapy, Leukotriene Antagonists therapeutic use, Lipoxygenase Inhibitors therapeutic use
Abstract

Asthma is a chronic inflammatory disorder of airways. It is characterised by bronchoconstriction, oedema and airways mucus hypersecretion. The main clinical features of asthma are dyspnea, cough, wheezing and heaviness in the chest. The pathology of asthma is characterised by presence of many inflammatory mediators, where the most important are cysteinyl leukotriens. Leukotriens C4, D4 and E4 are 1000 times more potent than histamine in contracting airways smooth muscles. Inhibitors of arachidonic acid metabolism have been used in asthma treatment. They can block the 5-lipoxygenase enzyme and/or 5-lipoxygenase-activating-proteine (FLAP), or can block the cysteinyl leukotriene receptors on the cell surface. Many inhibitors of arachidonic acid metabolism have been found during experimental trials. But only two are used as a drugs: zafirlukast and montelukast (leukotriene receptor inhibitors) montelukast and zileuton (5-lipoxygenase inhibitors) having the best efficacy in asthma treatment. Chronic treatment with these drugs results in a decrease of asthmatic symptoms, improvement of lung function (FEV1, PEF) and decreased usage of other medications--beta-adrenergic agonists and inhaled steroids. It has been proved that zafirlukast and zileuton show the high efficacy in mild-to-moderate asthma, exercise-induced asthma, allergen-induced asthma and aspirin-induced asthma. These oral drugs have been shown to course only mild adverse effects (such as temporary elevation in liver function tests, gastrointestinel disturbances, headache). Clinical usage of zafirlukast, montelukast and zileuton is limited in our country, they are hardly approachable on the market and the cost of treatment is high.

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results